Hsa-miR-221 is up-regulated in several types of cancer, directly induced by TP53 and able to targets several downstream effectors of the TP53 pathway as BBC3/PUMA, BMF, PTEN and MDM2 [131,132,133,134]. This evidence concerns the gene PTEN and cancer.